Home › Kidney Diseases › New York › New York City
Kidney Diseases clinical trials in New York City, NY
5 studies for Kidney Diseases are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
RecruitingPhase 3
- Icahn School of Medicine at Mount Sinai, New York
A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
RecruitingPhase 3
- NYU Langone Health, New York
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
RecruitingObservational study
- Columbia University Cystic Fibrosis Program, New York
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
RecruitingPhase 3
- Icahn School of Medicine at Mount Sinai, New York
Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)
RecruitingObservational study
- The Rogosin Institute, New York
About Kidney Diseases
Properly functioning kidneys are critical for maintaining good health. Diabetes, high blood pressure, or family history can increase risk of kidney disease.
More about Kidney Diseases on MedlinePlus
Kidney Diseases trials in other cities
- Atlanta, GA11 studies
- Houston, TX8 studies
- Orlando, FL7 studies
- Miami, FL6 studies
- Durham, NC5 studies
- Philadelphia, PA5 studies
- Dallas, TX5 studies
- Los Angeles, CA4 studies
- Cedar Rapids, IA4 studies
- Winston-Salem, NC4 studies
- Boston, MA4 studies
- Washington, DC4 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.